Immunotherapy of Cancer by Targeting Regulatory T cells.

Chen, Bo-Jin; Zhao, Jing-Wen; Zhang, Da-Hong; Zheng, Ai-Hong; Wu, Guo-Qing

Chen, Bo-Jin; Zhao, Jing-Wen; Zhang, Da-Hong; Zheng, Ai-Hong; Wu, Guo-Qing.

Afiliação

Chen BJ; The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Zhao JW; The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Zhang DH; Department of Urology Center, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Zheng AH; Department of Oncology Center, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China. Electronic address: zah05818898@163.com.
Wu GQ; Department of Oncology Center, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China. Electronic address: gqwuzsu@hotmail.com.

Int Immunopharmacol ; 104: 108469, 2022 Mar.

Article em En | MEDLINE | ID: mdl-35008005

Assuntos

Imunoterapia; Neoplasias/terapia; Linfócitos T Reguladores/imunologia; Animais; Humanos; Neoplasias/imunologia; Receptores de Citocinas/imunologia

Palavras-chave

Cytokine receptors(4); Immune checkpoint(3); Immunotherapy(1); Tumor immunology(5); regulatory T cell(2)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Reguladores / Imunoterapia / Neoplasias Limite: Animals / Humans Idioma: En Revista: Int Immunopharmacol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google